Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunosuppression Disorders”

489 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 489 results

Testing effectiveness (Phase 2)Ended earlyNCT02452424
What this trial is testing

A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+2 more
Daiichi Sankyo 78
Large-scale testing (Phase 3)Ended earlyNCT04258423
What this trial is testing

Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney Function

Who this might be right for
Kidney Failure
Indiana University 4
Testing effectiveness (Phase 2)Study completedNCT00001862
What this trial is testing

TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis

Who this might be right for
Juvenile Rheumatoid ArthritisUveitis
National Eye Institute (NEI) 15
Not applicableStudy completedNCT05685888
What this trial is testing

Effect of Ursodeoxycholic Acid on Preventing Covid-19 Infection in Patients With Organ Transplantation

Who this might be right for
Organ TransplantationCOVID-19
First Affiliated Hospital Xi'an Jiaotong University 2,000
Not applicableLooking for participantsNCT07074951
What this trial is testing

Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy

Who this might be right for
Primary IgA-nephropathyHigh-riskCaucasians
St. Petersburg State Pavlov Medical University 240
Early research (Phase 1)Study completedNCT00255710
What this trial is testing

Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Testing effectiveness (Phase 2)Study completedNCT00668369
What this trial is testing

Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver Transplantation

Who this might be right for
Hepatitis C Virus InfectionLiver Transplantation
Hospital Clinic of Barcelona 34
Testing effectiveness (Phase 2)Study completedNCT00021788
What this trial is testing

Islet Cell Transplantation Alone in Patients With Type I Diabetes Mellitus: Steroid-free Immunosuppression

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Early research (Phase 1)Study completedNCT00324623
What this trial is testing

Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Prof. Serge Leyvraz 8
Testing effectiveness (Phase 2)WithdrawnNCT03606746
What this trial is testing

Cellular Immunotherapy for Immune Tolerance in Past Recipients of HLA Zero-mismatch, Living Donor Kidney Transplants

Who this might be right for
Kidney Transplant Rejection
Medeor Therapeutics, Inc.
Early research (Phase 1)Study completedNCT04199715
What this trial is testing

Safety and Efficacy of a Hepatitis B Vaccine in Immunosuppressed Patients

Who this might be right for
Hepatitis B
Baylor Research Institute 10
Early research (Phase 1)Not Yet RecruitingNCT07302776
What this trial is testing

TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

Who this might be right for
GVHDHematopoietic Cell Transplantation (HCT)Acute Myeloid Leukemia (AML)+4 more
Stanford University 50
Large-scale testing (Phase 3)Study completedNCT00707759
What this trial is testing

Steroid Withdrawal in Pediatric Renal Transplant: Impact on Growth, Bone Metabolism and Acute Rejection

Who this might be right for
Kidney Diseases
Fondo Nacional de Desarrollo Científico y Tecnológico, Chile 28
Not applicableActive Not RecruitingNCT04916704
What this trial is testing

Subclinical Cytomegalovirus Reactivation in Acute ANCA-associated Vasculitis

Who this might be right for
ANCA Associated Vasculitis
University Hospital Birmingham NHS Foundation Trust 70
Not applicableActive Not RecruitingNCT05816538
What this trial is testing

The Immune Response of Breast Cancer Patients Treated With Levobupivacaine Using Paravertebral or Superficial Chest Blocks

Who this might be right for
Paravertebral BlockPectoralis and Serratus Plane Nerve BlocksBreast Cancer+2 more
University of Rijeka 100
Not applicableStudy completedNCT00014235
What this trial is testing

Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia/Transient Myeloproliferative DisorderAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+74 more
Fred Hutchinson Cancer Center 160
Post-approval studies (Phase 4)Study completedNCT00812123
What this trial is testing

Calcineurin Free Immunosuppression in Renal Transplant Recipients

Who this might be right for
Kidney TransplantationChronic Kidney Disease
University Hospital, Basel, Switzerland 127
Not applicableUnknownNCT03806764
What this trial is testing

Cytomegalovirus (CMV) Reactivation in Allogeneic HSCT Recipient

Who this might be right for
Cytomegalovirus InfectionsHaematological MalignancyOrgan or Tissue Transplant; Complications+1 more
Melbourne Health 370
Testing effectiveness (Phase 2)Looking for participantsNCT06778434
What this trial is testing

The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans

Who this might be right for
Actinic KeratosisImipraminePhotodynamic Therapy
VA Office of Research and Development 48
Testing effectiveness (Phase 2)Study completedNCT01853618
What this trial is testing

Tremelimumab With Chemoembolization or Ablation for Liver Cancer

Who this might be right for
Heptocellular CancerBiliary Tract NeoplasmsLiver Cancer+2 more
National Cancer Institute (NCI) 61
Load More Results